Inventiva S.A. (Nasdaq: IVA), an SEC filer in Pharmaceutical Preparations, closed at $4.71, -4.0%, on 2026-08-28. Institutional ownership, earnings history and filed financials are on the tabs below.
Returns use ADJUSTED closes (splits + dividends).
Volume as VALUE TRADED — close × volume, in USD.
| Year | Jan | Feb | Mar | Apr | May | Jun | Jul | Aug | Sep | Oct | Nov | Dec | IVA | SPY | Δ |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 2026 · ytd | +32.5% | +5.4% | −14.5% | −7.6% | −3.9% | −23.3% | +18.5% | +5.0% | — | — | — | — | +1.2% | +13.4% | −12.2pp |
| 2025 | +13.3% | +30.7% | −7.3% | +25.9% | −8.4% | −5.9% | +4.9% | +85.1% | −6.5% | −25.7% | −1.2% | +9.4% | +117.3% | +17.7% | +99.6pp |
| 2024 | −15.9% | −4.7% | +0.0% | −15.2% | +19.5% | −18.5% | −23.4% | −1.1% | −17.7% | +42.6% | −0.4% | −19.2% | −52.6% | +24.9% | −77.5pp |
| 2023 | +39.5% | −17.9% | −28.8% | −25.3% | +45.0% | +2.4% | +1.2% | −9.5% | +13.5% | −10.0% | +11.1% | +7.5% | +1.3% | +26.2% | −24.9pp |
| 2022 | −11.6% | +10.9% | −14.9% | −17.5% | −4.0% | −37.1% | −15.4% | −6.2% | −12.6% | +16.5% | −8.8% | +6.8% | −67.3% | −18.2% | −49.2pp |
| 2021 · part | — | — | −2.0% | −8.7% | +1.8% | −0.2% | −1.4% | −1.8% | +7.3% | +10.5% | −15.0% | +2.7% | −8.9% | +28.7% | −37.7pp |
Month-end over prior month-end; a blank cell is no return.
Basis. Both columns share one basis, so Δ is like-for-like.
End-of-day closes; a “ytd” or “part” year is not a full year.
| Month | Jan | Feb | Mar | Apr | May | Jun | Jul | Aug | Sep | Oct | Nov | Dec |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Years ⓘ | 5 | 5 | 6 | 6 | 6 | 6 | 6 | 6 | 5 | 5 | 5 | 5 |
| Positive ⓘ | 60% | 60% | 0% | 17% | 50% | 17% | 50% | 33% | 40% | 60% | 20% | 80% |
| Median | +13.3% | +5.4% | −10.9% | −11.9% | −1.1% | −12.2% | −0.1% | −1.4% | −6.5% | +10.5% | −1.2% | +6.8% |
| Best | +39.5% | +30.7% | +0.0% | +25.9% | +45.0% | +2.4% | +18.5% | +85.1% | +13.5% | +42.6% | +11.1% | +9.4% |
| Worst | −15.9% | −17.9% | −28.8% | −25.3% | −8.4% | −37.1% | −23.4% | −9.5% | −17.7% | −25.7% | −15.0% | −19.2% |
| vs SPY ⓘ | +10.7pp | +6.2pp | −8.0pp | −12.6pp | −1.6pp | −16.5pp | −3.0pp | −2.7pp | −3.4pp | +3.5pp | −6.3pp | +3.0pp |
66 monthly observations · 2021–2026 · benchmark SPY
